“Zanolimumab (Humax-CD4), a Fully Human Monoclonal Antibody With Significant Clinical Responses in Cutaneous T-Cell Lymphoma”. Hematology Meeting Reports (formerly Haematologica Reports) 3, no. 1 (June 11, 2009). Accessed June 20, 2025. https://journals.pagepress.org/hmr/article/view/540.